CYP7A1 and hyperlipidemia: Therefore, taken together, these results revealed that AEE ameliorated hyperlipidemia via regulating liver and fecal metabolomics profiles, FXR-mediated upregulating of CYP7A1, and upregulating G-BA levels and downregulating T-BA levels.